Modified nucleoside triphosphates for in-vitro selection techniques

Frontiers in Chemistry

Volumn 4, Issue MAY, 2016, Pages

  Dellafiore, María A ^a   Montserrat, Javier M ^a,b   Iribarren, Adolfo M ^a,c  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b INSTITUTO DE CIENCIAS   (Argentina)

^c UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Aptamers; DNAzymes; Functional oligonucleotides; Modified nucleotides; Ribozymes; SELEX

Indexed keywords

EID: 84992692368     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2016.00018     Document Type: Review

References (134)

1. Aurup, H., Williams, D. M., and Eckstein, F. (1992). 2'-Fluoro-and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31, 9636-9641. doi: 10.1021/bi00155a016
2. Battersby, T. R., Ang, D. N., Burgstaller, P., Jurczyk, S. C., Bowser, M. T., Buchanan, D. D., et al. (1999). Quantitative analysis of receptors for adenosine nucleotides obtained via in vitro selection from a library incorporating a cationic nucleotide analog. J. Am. Chem. Soc. 121, 9781-9789. doi: 10.1021/ja9816436
3. Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H., and Toole, J. J. (1992). Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564-566. doi: 10.1038/355564a0
4. Bouchard, P. R., Hutabarat, R. M., and Thompson, K. M. (2010). Discovery and development of therapeutic aptamers. Annu. Rev. Pharmacol. Toxicol. 50, 237-257. doi: 10.1146/annurev.pharmtox.010909.105547
5. Burgess, K., and Cook, D. (2000). Syntheses of nucleoside triphosphates. Chem. Rev. 100, 2047-2059. doi: 10.1021/cr990045m
6. Burmeister, P., Lwis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., et al. (2005). Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. Chem. Biol. 12, 25-33. doi: 10.1016/j.chembiol.2004.10.017
7. Burmeister, P. E., Wang, C., Killough, J. R., Lewis, S. D., Horwitz, L. R., Ferguson, A., et al. (2006). 2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics. Oligonucleotides 16, 337-351. doi: 10.1089/oli.2006.16.337
8. Carroll, S. S., Tomassini, J. E., Bosserman, M., Getty, K., Stahlhut, M. W., Eldrup, A. B., et al. (2003). Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs. J. Biol. Chem. 278, 11979-11984. doi: 10.1074/jbc.M210914200
9. Caton-Williams, J., Hoxhaj, R., Fiaz, B., and Huang, Z. (2013). Use of a novel 5-regioselective phosphitylating reagent for one-pot synthesis of nucleoside 5-triphosphates from unprotected nucleosides. Curr. Protocol Nucleic Acid Chem. Chapter 1:Unit 1.30. doi: 10.1002/0471142700.nc0130s52
10. Caton-Williams, J., Lin, L., Smith, M., and Haung, Z. (2011a). Convenient synthesis of nucleoside 5-triphosphates for RNA transcription. Chem.Commun. 47, 8142-8144. doi: 10.1039/c1cc12201k
11. Caton-Williams, J., Smith, M., Carrasco, N., and Huang, Z. (2011b). Protection-free one-pot synthesis of 2-deoxynucleoside 5-triphosphatesand DNA polymerization. Org. Lett. 13, 4156-4159. doi: 10.1021/ol201073e
12. Chelliserrykattil, J., and Ellington, A. D. (2004). Evolution of a T7 RNA polymerase variant that transcribes 2'-O-methyl RNA. Nat. Biotechnol. 22, 1155-1160. doi: 10.1038/nbt1001
13. Chen, T., and Romesberg, F. E. (2014). Directed polymerase evolution. FEBS Lett. 588, 219-229. doi: 10.1016/j.febslet.2013.10.040
14. Conrad, F., Hanne, A., Gaur, R. K., and Krupp, G. (1995). Enzymatic synthesis of 2'-modified nucleic acids: identification of important phosphate and ribose moieties in RNase P substrates. Nucleic Acids Res. 23, 1845-1853. doi: 10.1093/nar/23.11.1845
15. Cozens, C., Mutschler, H., Nelson, G. H., Houlihan, G., Taylor, A. I., and Holliger, P. (2015). Enzymatic synthesis of nucleic acids with defined regioisomeric 2'-5'-linkages. Angew. Chem. Int. Ed Engl. 54, 15570-15573. doi: 10.1002/anie.201508678
16. Diafa, S., and Hollenstein, M. (2015). Generation of aptamers with an expanded chemical repertoire. Molecules 20, 16643-16671. doi: 10.3390/molecules200916643
17. Dupont, D. M., Madsen, J. B., Harmann, R. K., Tavitian, B., Ducougé, F., Kjens, J., et al. (2010). Serum-stable RNA aptamers to urodinase-ype plasminogen activator blocking receptor binding. RNA 16, 2360-2369. doi: 10.1261/rna.2338210
18. Dutartre, H., Bussetta, C., Boretto, J., and Canard, B. (2006). General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2'-modified nucleotide analogues. Antimicrob. Agents Chemother. 50, 4161-4169. doi: 10.1128/AAC.00433-06
19. Ellington, A. D., and Szostak, J. W. (1990). Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 346, 818-822. doi: 10.1038/346818a0
20. Eulberg, D., Jarosch, F., Vonhoff, S., and Klussmann, S. (2006). "Spiegelmers for therapeutic applications-use of chiral principles in evolutionary selection techniques," in The Aptamer Handbook, ed S. Klussmann (Weinheim: Wiley-VCH), 417-442.
21. Fa, M., Radeghieri, A., Henry, A. A., and Romesberg, F. (2004). Expanding the substrate repertoire of a DNA polymerase by directed evolution. J. Am. Chem. Soc. 126, 1748-1754. doi: 10.1021/ja038525p
22. Förster, C. H., Zydek, M., Rothkegel, M., Wu, Z., Gallin, C., Geßner, R., et al. (2012). Properties of an 'LNA'-modified ricin RNA aptamer. Biochem. Biophys. Res. Commun. 419, 60-65. doi: 10.1016/j.bbrc.2012.01.127
23. Friedman, A. D., Kim, D., and Li, R. (2015). Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials. Biomaterials 36, 110-123. doi: 10.1016/j.biomaterials.2014.08.046
24. Ghadessy, F. J., Ramsay, N., Boudsocq, F., Loakes, D., Brown, A., Iwai, S., et al. (2004). Generic expansion of the substrate spectrum of a DNA polymerase by directed evolution. Nat. Biotechnol. 22, 755-759. doi: 10.1038/nbt974
25. Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., et al. (1995). Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2, 683-695. doi: 10.1016/1074-5521(95)90032-2
26. Gregson, J. M., Crain, P. F., Edmonds, C. G., Gupta, R., Hashizume, T., Phillipson, D. W., et al. (1993). Structure of the archaeal transfer RNA nucleoside G*-15 (2-amino-4,7-dihydro-4-oxo-7-beta-D-ribofuranosyl-1H-pyrrolo[2,3-d]pyrimidine-5-carboximidamide (archaeosine)). J. Biol. Chem. 268, 10076-10086.
27. Hansen, C. J., Wu, L., Fox, J. D., Arezi, B., and Hogrefe, H. H. (2011). Engineered split in Pfu DNA polymerase fingers domain improves incorporation of nucleotide gamma-phosphate derivatives. Nucleic Acids Res. 39, 1801-1810. doi: 10.1093/nar/gkq1053
28. Helm, M., and Alfonzo, J. D. (2014). Posttranscriptional RNA modifications: playing metabolic games in a cell's chemical legoland. Chem. Biol. 21, 174-185. doi: 10.1016/j.chembiol.2013.10.015
29. Henry, A. A., and Romesberg, F. E. (2005). The evolution of DNA polymerases with novel activities. Curr. Opin. Biotechnol. 16, 370-377. doi: 10.1016/j.copbio.2005.06.008
30. Higashimoto, Y., Matsui, T., Nishino, Y., Taira, J., Inoue, H., Takeuchi, M.i., et al. (2013). Blockade by phosphorothitate aptamers of advanced glycation en products-induced damage in cultured pericytes and endothelial cells. Microvasc. Res. 90, 64-70. doi: 10.1016/j.mvr.2013.08.010
31. Hollenstein, M. (2012a). Nucleoside triphosphates-building blocks for the modification of nucleic acids. Molecules 17, 13569-13591. doi: 10.3390/molecules171113569
32. Hollenstein, M. (2012b). Synthesis of deoxynucleoside triphosphates that include proline, urea, or sulfonamide groups and their polymerase incorporation into DNA. (2012). Chem. Eur. J. 18, 13320-13330. doi: 10.1002/chem.201201662
33. Hollenstein, M., Hipolito, C. H. J., Lam, C. H., and Perrin, D M. (2009). A DNAzyme with three protein-like functional groups: enhancing Catalytic Efficiency of M2+-Independent RNA Cleavage. Chembiochem 10, 1988-1601. doi: 10.1002/cbic.200900314
34. Horiya, S., MacPherson, I. S., Isaac, J., and Krauss, I. J. (2014). Recent strategies targeting HIV glycans in vaccine design. Nat. Chem. Biol. 10, 990-999. doi: 10.1038/nchembio.1685
35. Huizenga, D. E., and Szostak, J. W. (1995). Aptamer that binds adenosine and ATP. Biochemistry 34, 656-665. doi: 10.1021/bi00002a033
36. Iannitti, T., Morales-Medina, J. C., and Palmieri, B. (2014). Phosphorothioate oligonucleotides: effectiveness and toxicity. Curr. Drug Targets 15, 663-673. doi: 10.2174/1389450115666140321100304
37. Iglesias, L. E., Lewkowicz, E. S., Medici, R., Bianchi, P., and Iribarren, A. M. (2015). Biocatalytic approaches applied to the synthesis of nucleoside prodrugs. Biotechnol. Adv. 33, 412-434. doi: 10.1016/j.biotechadv.2015.03.009
38. Imaizumi, Y., Ksahara, Y., Fujita, H., Kitaduma, S., Ozaki, H., Endoh, T., et al. (2013). Efficacy of base-modification of target binding of small molecules DNA Aptamers. J. Am. Chem. Soc. 135, 9412-9419. doi: 10.1021/ja4012222
39. Jayasena, S. D. (1999). Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45, 1628-1650.
40. Jellinek, D., Green, L. S., Bell, C., Lynott, C. K., Gill, N., Vargeese, C. H., et al. (1995). Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34, 11363-11372. doi: 10.1021/bi00036a009
41. Jhaveri, S., Olwin, B., and Ellington, A. D. (1998). In vitro selection of phosphorothilated aptamers. Bioorg. Med. Chem. Lett. 8, 2285-2290. doi: 10.1016/S0960-894X(98)00414-4
42. Kang, J., Lee, M. S., Copland, J. A. III, Luxon, B. A., and Gorenstein, D. G. (2008). Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-b1 protein. Bioorg. Med. Chem. Lett. 18, 1835-1839. doi: 10.1016/j.bmcl.2008.02.023
43. Kasahara, Y., Irisawa, Y., Ozaki, H., Obika, S., and Kuwahara, M. (2013). 2',4'-BNA/LNA aptamers: CE-SELEX using a DNA-based library of full-length 2'-O,4'-C-methylene bridged/linked bicyclic ribonucleotides. Bioorg. Med. Chem. Lett. 23, 1288-1292. doi: 10.1016/j.bmcl.2012.12.093
44. Kato, Y., Minakawa, N., Komatzu, Y., Harashima, H., and Matsuda, A. (2005). New NTP analogs: the synthesis of 4'-thioUTP and 4'-thioCTP and their utility for SELEX. Nucleic Acid Res. 33, 2942-2951. doi: 10.1093/nar/gki578
45. Keffe, A. D., and Cload, S. T. (2008). SELEX with modified nucleotides. Curr. Op. Chem. Biol. 12, 448-456. doi: 10.1016/j.cbpa.2008.06.028
46. Kimoto, M., Matsunaga, K., and Hirao, I. (2016). DNA Aptamer generation by genetic alphabet expansion SELEX (ExSELEX) using an unnatural base pair system. Methods Mol. Biol. 1380, 47-60. doi: 10.1007/978-1-4939-3197-2_4
47. Kimoto, M., Yamashige, R., Matsunaga, K., Yokoyama, S., and Hirao, I. (2013). Generation of high-affinity DNA aptamers using and expanded genetic alphabet. Nat. Biotechnol. 31, 453-457. doi: 10.1038/nbt.2556
48. Klussmann, S. (Ed.). (2006). The Aptamer Handbook. Functional Oligonucleotides and Their Applications. Weinheim: WILEY-VCH.
49. Kong, H. Y., and Bym, J. (2013). Nucleic acid aptamers: new methods for selection, stabilization and application in biomedical science. Biomol. Ther. 21, 423-434. doi: 10.4062/biomolther.2013.085
50. Kore, A. R., and Srinivasan, B. (2013). Recent advances in the syntheses of nucleoside triphosphates. Curr. Org. Synth. 10, 903-934. doi: 10.2174/15701794113109990001
51. Korhonen, H. J., Bolt, H. L., Vicente-Gines, L., Perks, D. C., and Hodgson, D. R. W. (2015). PPN pyrophosphate: a new reagent for the preparation of nucleoside triphosphates. Phosphorus Sulfur Silicon Relat. Elem. 190, 758-762. doi: 10.1080/10426507.2014.984032
52. Kuwahara, M., Hanawa, K., Ohsawa, K., Kitagata, R., Ozaki, H., and Sawai, H. (2006). Direct PCR amplification of various modified DNAs having amino acids: convenient preparation of DNA libraries. Bioorg. Med. Chem. 14, 2518-2526. doi: 10.1016/j.bmc.2005.11.030
53. Kuwahara, M., Obika, S., Nagashima, J., Ohta, Y., Suto, Y., Ozaki, H., et al. (2008). Systematic analysis of enzymatic DNA polymerization using oligo-DNA templates and triphosphate analogs involving 2',4'-bridged nucleosides. Nucleic Acids Res. 36, 4257-4265. doi: 10.1093/nar/gkn404
54. Kuwahara, M., Takahata, Y., Shoji, A., Ozaki, A. N., Ozaki, H., and Sawai, H. (2003). Substrate properties of C5-substituted pyrimidine 2'-deoxynucleoside 5'-triphosphates for thermostable DNA polymerases during PCR. Bioorg. Med. Chem. Lett. 13, 3735-3738. doi: 10.1016/j.bmcl.2003.08.001
55. Laos, R., Shaw, R., Leal, N. A., Gaucher, E., and Benner, S. (2013). Directed evolution of polymerases to accept nucleotides with nonstandard hydrogen bond patterns. Biochemistry 52, 5288-5294. doi: 10.1021/bi400558c
56. Laos, R., Thomson, J. M., and Benner, S. A. (2014). DNApolymerases engineered by directed evolution to incorporate non-standard nucleotides. Front. Microbiol. 5:565. doi: 10.3389/fmicb.2014.00565
57. Lapa, S. A., Chudinov, A. V., and Timofeev, E. N. (2016). The toolbox for modified aptamers. Mol. Biotechnol. 58, 79-92. doi: 10.1007/s12033-015-9907-9
58. Latham, J. A., Johnson, R., and Toole, J. J. (1994). The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2-0-deoxyuridine. Nucleic Acids Res. 22, 2817-2822. doi: 10.1093/nar/22.14.2817
59. Lato, S. M., Ozerova, N. D., He, K., Sergueevfe, Z., Shaw, B. R., and Burke, D. H. (2002). Boron-containing aptamers. Nucleic Acids Res. 30, 1401-1407. doi: 10.1093/nar/30.6.1401
60. Lauridsen, L. H., Rothnagel, J. A., and Veedu, R. N. (2012). Enzymatic Recognition of 2'-Modified Ribonucleoside5'-Triphosphates: towards the evolution of versatile aptamers. Chembiochem 13, 19-25. doi: 10.1002/cbic.201100648
61. Leconte, A. M., Chen, L., and Romesberg, F. E. (2005). Polymerase evolution: efforts toward expansion of the genetic code. J. Am. Chem. Soc. 127, 12470-12471. doi: 10.1021/ja053322h
62. Lee, K., Rafi, M., Wang, X., Aran, K., Feng, X., Lo Sterzo, C., et al. (2015). In vivo delivery of transcription factors with multifunctional oligonucleotides. Nat. Mater. 14, 701-706. doi: 10.1038/nmat4269
63. Li, M., Lin, N., Huang, Z., Du, L., Huang, Z., Du, L., et al. (2008). Selecting aptamers for a glycoprotein through the incorporation of the boronic acid moiety. J. Am. Chem. Soc. 130, 12636-12638. doi: 10.1021/ja801510d
64. Li, Y., and Lu, Y. (Eds.). (2009). Functional Nucleic Acids for Analytical Applications. New York, NY: Springer.
65. Limbach, P. A., Crain, P. F., and McCloskey, J. A. (1994). Summary: the modified nucleosides of RNA. Nucleic Acids Res. 22, 2183-2196. doi: 10.1093/nar/22.12.2183
66. Lin, Y., Qiu, Q., Gill, S. C., and Jayasena, S. D. (1994). Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 22, 5229-5234. doi: 10.1093/nar/22.24.5229
67. Liu, E., Lam, C. H., and Perrin, D. M. (2015). Synthesis and enzymatic incorporation of modified deoxyuridine triphosphates. Molecules 20, 13591-13602, doi: 10.3390/molecules200813591
68. Liu, M., Jinmei, H., Abe, H., and Ito, Y. (2010). In vitro selection of a photoresponsieve RNA aptamer to hemin. Bioorg. Med. Chem. Lett. 20, 2964-2967. doi: 10.1016/j.bmcl.2010.02.109
69. Loakes, D., Gallego, J., Pinheiro, V. B., Kool, E. T., and Holliger, P. (2009). Evolving a polymerase for hydrophobic base analogues. J. Am. Chem. Soc. 131, 14827-14837. doi: 10.1021/ja9039696
70. Ludwig, J. (1981). A new route to nucleoside 5'-triphosphates. Acta Biochim. Biophys. Acad. Sci. Hung. 16, 131-133.
71. Ludwig, J., and Eckstein, F. (1989). Rapid and efficient synthesis of nucleoside 5'-0-(1-thiotriphosphates), 5'-triphosphates and 2',3'-cyclophosphorothioates using 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-one. J. Org. Chem. 54, 631-635. doi: 10.1021/jo00264a024
72. Macková, M., Pohl, R., and Hocek, M. (2014). Polymerase synthesis of DNAs bearing vinyl groups in themajor groove and their cleavage by restriction endonucleases. Chembiochem 15, 2306-2312. doi: 10.1002/cbic.201402319
73. Mascini, M. (ed.). (2009). Aptamers in Bioanalysis. New Jersey, NY: John Wiley & Sons.
74. Masud, M., Kuhahara, M., Ozaki, M., and Sawai, H. (2004). Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX. Bioorg. Med. Chem. 12, 1111-1120. doi: 10.1016/j.bmc.2003.12.009
75. Meyer, A. J., Garry, D. J., Hall, B., Byrom, M. M., McDonald, H. G., Yang, X., et al. (2015). Transcription yield of fully 2'-modified RNA can be increased by the addition of thermostabilizing mutations to T7 RNA polymerase mutants. Nucleic Acids Res. 43, 7480-7488. doi: 10.1093/nar/gkv734
76. Minikawa, N., Sanji, M., Kato, Y., and Matsuda, A. (2008). Investigations toward the selection of a fully-modified 4'-thio RNA aptamers: optimization of in vitro transcription steps in the presence of 4'-thiNTPs. Bioorg. Med. Chem. 16, 9450-9456. doi: 10.1016/j.bmc.2008.09.048
77. Ng, E. W. M., Shima, D. T., Callias, P., Cunningham, E. T. Jr., Guyer, D. R., and Adamis, A.P. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature Revs. Drugs Discov. 5, 123-132. doi: 10.1038/nrd1955
78. Ochsner, U. A., Katilus, E., and Janjic, N. (2013). Detection of Clostridium difficile toxins A, B and binary toxin with slow off-rate modified aptamers. Diag. Micr. Infec. Dis. 76, 278-285. doi: 10.1016/j.diagmicrobio.2013.03.029
79. Ochsner, U. A., Green, L. S., Gold, L., and Janjic, N. (2014). Systematic selection of modified aptamer paris for diagnostic sandwich assays. Biotechniques 56, 125-133. doi: 10.2144/000114134
80. Ogawa, M., Tosaka, A., Ito, Y., Yoshida, S., and Suzuki, M. (2001). Enhanced ribonucleotide incorporation by an O-helix mutant of Thermus aquaticus DNA polymerase I. Mutat. Res. 485, 197-207. doi: 10.1016/S0921-8777(00)00081-1
81. Ong, J. L., Loakes, D., Jaroslawski, S., Too, K., and Holliger, P. (2006). Directed evolution of DNA polymerase, RNA polymerase and reverse transcriptase activity in a single polypeptide. J. Mol. Biol. 361, 537-550. doi: 10.1016/j.jmb.2006.06.050
82. Ono, T., Scalf, M., and Smith, L. M. (1997). 2'-Fluoro modified nucleic acids: polymerase-directed synthesis, properties and stability to analysis by matrix-assisted laser desorption/ionization mass spectrometry. Nucleic Acids Res. 25, 4581-4588. doi: 10.1093/nar/25.22.4581
83. Padilla, R., and Sousa, R. (1999). Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutant T7 RNA polymerase (RNAP). Nucleic Acids Res. 27, 1561-1563. doi: 10.1093/nar/27.6.1561
84. Padilla, R., and Sousa, R. (2002). A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs. Nucleic Acids Res. 30:e138. doi: 10.1093/nar/gnf138
85. Pagratis, N. C., Bell, C., Chang, Y.-F., Jennings, S., Fitzwater, T., Jellinek, D., et al. (1997). Potent 2'-amino, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 2215, 68-73. doi: 10.1038/nbt0197-68
86. Patel, P. H., Kawate, H., Adman, E., Ashbach, M., and Loeb, L. (2001). A single highly mutable catalytic site amino acid is critical for DNA polymerase fidelity. J. Biol. Chem. 276, 5044-5051. doi: 10.1074/jbc.M008701200
87. Patel, P. H., and Loeb, L. A. (2000). Multiple amino acid substitutions allow DNA polymerases to synthesize RNA. J. Biol. Chem. 275, 40266-40272. doi: 10.1074/jbc.M005757200
88. Pavey, J. B., Lawrence, A. J., O'Neil, I. A., Vortler, S., and Cosstick, R. (2004). Synthesis and transcription studies on 5'-triphosphates derived from 2'-C-branched-uridines: 2'-homouridine-5'-triphosphate is a substrate for T7 RNA polymerase. Org. Biomol. Chem. 2, 869-875. doi: 10.1039/B314348A
89. Peinetti, A. S., Ceretti, H., Mizrahi, M., González, G. A., Ramírez, S. A., Requejo, F., et al. (2015).Confined gold nanoparticles enhance the detection of small molecules in label free impedance aptasensors. Nanoscale 7, 7763-7769. doi: 10.1039/C5NR01429H
90. Peng, C. G., and Damha, M. J. (2007). Polymerase-directed synthesis of 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acids. J. Am. Chem. Soc. 129, 5310-5311. doi: 10.1021/ja069100g
91. Perrin, D. M., Garestier, T., and Hélène, C. (1999). Expanding the catalytic repertoire of nucleic acids catalysts: simultaneous incorporation of two modified deoxyribonucleoside triphosphates bearing ammonium and imidazolyl functionalities. Nucleosides Nucleotides 18, 377-391.
92. Pinheiro, V. B., Taylor, A. I., Cozens, C., Abramov, M., Renders, M., Zhang, S., et al. (2012). Synthetic genetic polymers capable of heredity and evolution. Science 336, 341-344. doi: 10.1126/science.1217622
93. Pontiggia, R., Pontiggia, O., Simian, M., Montserrat, J. M., Engels, J. W., and Iribarren, A. M. (2010). 2'-Methyluridine modified hammerhead ribozyme against the Estrogen Receptor a. Bioorg. Med. Chem. Lett. 20, 2806-2808. doi: 10.1016/j.bmcl.2010.03.060
94. Raines, K., and Gottlieb, P. A. (1998). Enzymatic incorporation of 2'-thio-CTP into the HDV ribozyme. RNA 4, 340-345.
95. Ramsay, N., Jemth, A. S., Brown, A., Crampton, N., Dear, P., and Holliger, P. (2010). CyDNA: synthesis and replication of highly Cy-dye substituted DNA by an evolved polymerase. J. Am. Chem. Soc. 132, 5096-5104. doi: 10.1021/ja909180c
96. Richardson, F. C., Kuchta, R. D., Mazurkiewicz, A., and Richardson, K. A. (2000). Polymerization of 2'-fluoro-and 2'-O-methyl-dNTPs by human DNA polymerase alpha, polymerase gamma, and primase. Biochem. Pharmacol. 59, 1045-1052. doi: 10.1016/S0006-2952(99)00414-1
97. Robaldo, L., Berzal-Herranz, A., Montserrat, J. M., and Iribarren, A. M. (2014). Activity of core modified 10-23 DNAzymes against HCV. Chem. Med. Chem. 9, 2271-2277. doi: 10.1002/cmdc.201402222
98. Robertson, D. L., and Joyce, G. F. (1990). Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344, 467-468. doi: 10.1038/344467a0
99. Rodríguez, L., Villalobos, X., Solé, A., Lliberós, C., Ciudad, C. J., and Noé, V. (2015). Improved design of PPRHs for gene silencing. Mol. Pharm. 12, 867-877. doi: 10.1021/mp5007008
100. Rohloff, J. C., Fowler, C., Ream, B., Carter, J. D., Wardle, G., and Fitzwater, T. (2015). Practical synthesis of cytidine-5-carboxamide-modified nucleotide reagents. Nucleosides Nucleotides Nucleic Acids 34, 180-198. doi: 10.1080/15257770.2014.978011
101. Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., et al. (2014). Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucleic Acids 3, e201-e203. doi: 10.1038/mtna.2014.49
102. Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Guillette, W. L., Henninger, D. D., et al. (1998). 2'-Fluoropyrimidine RNA-based Aptamers to the 165-amino acid from of vascular endothelial growth factor (VEFG165). J. Biol. Chem. 273, 20556-20567. doi: 10.1074/jbc.273.32.20556
103. Santoro, S. W., Joyce, G. F., Sakthivel, K., Gramatikova, S., and Barbas, C. F. III. (2000). RNA Cleavage by a DNA enzyme with extended chemical functionality. J. Am. Chem. Soc. 122, 2433-2439. doi: 10.1021/ja993688s
104. Schmid-Kubista, K. E., Krebs, I., Ansari-Shahrezaei, S., Haas, P., Hagen, S., and Binder, S. (2011). Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal avastin and macugen versus intravitreal mono-therapy-A pilot study. Curr. Eye Res. 36, 958-963. doi: 10.3109/02713683.2011.597536
105. Schultz, H. J., Gochi, A. M., Chia, H. E., Ogonowsky, A. L., Chiang, S., Filipovic, N., et al. (2015). Taq DNA Polymerase mutants and 2'-modified sugar recognition. Biochemistry 54, 5999-6008. doi: 10.1021/acs.biochem.5b00689
106. Sczepanski, J. T., and Joyce, G. F. (2013). Binding of a Structured D-RNA Molecule by and L-RNA Aptamer. J. Am. Chem. Soc. 135, 13290-13293. doi: 10.1021/ja406634g
107. Shinkai, A., Patel, P. H., and Loeb, L. H. (2001). The conserved active site motif A of Escherichia coli DNA polymerase I is highly mutable. J. Biol. Chem. 276, 18836-18842. doi: 10.1074/jbc.M011472200
108. Shoji, A., Kuwahara, M., Ozaki, H., and Sawai, H. (2007). Modified DNA Aptamer that Binds the (R)-isomer of a thalidomide derivatie with high enantioselectivity. J. Am. Chem. Soc. 129, 1456-1464. doi: 10.1021/ja067098n
109. Sidorov, A. V., Grasby, J. A., and Williams, D. M. (2004). Sequence-specific cleavage of RNA in the absence of divalent metal ions by a DNAzyme incorporating imidazolyl and amino functionalities. Nucleic Acids Res. 32, 1591-1601. doi: 10.1093/nar/gkh326
110. Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X., Neerathilingam, M., Lokesh, G. L. R., et al. (2010). Combinatorial Selection of DNA Thioaptamers Targeted to HA Binding Domain of CD44. Biochemistry 49, 9106-9112. doi: 10.1021/bi1009503
111. Staffan, E. (2005). "Enzymatic synthesis of nucleoside triphosphates," in Nucleoside Triphosphates and Their Analogs, ed M. Vaghefi (Boca Raton, FL: CRC Press), 23-37.
112. Sun, H., and Zu, Y. (2015). A highlight of recent advances in aptamer technology and its application. Molecules 20, 11959-11980. doi: 10.3390/molecules200711959
113. Suzuki, M., Baskin, D., Hood, L., and Loeb, L. (1996). Random mutagenesis of Thermus aquaticus DNA polymerase I: concordance of immutable sites in vivo with the crystal structure. Proc. Natl. Acad. Sci. U.S.A. 93, 9670-9675. doi: 10.1073/pnas.93.18.9670
114. Svobodova, M., Bunka, D. H. H., Nadal, P., Stockley, P. G., and O'sullivan, C. K. (2013). Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications. Anal. Bioanal. Chem. 405, 9149-9157. doi: 10.1007/s00216-013-7350-y
115. Tarasow, T. M., Tarasow, S. L., and Eaton, B. E. (1997). RNA-catalysed carbon-carbon bond formation. Nature 389, 54-57. doi: 10.1038/37950
116. Taylor, A. I., and Holliger, P. (2015). Direct evolution of artificial enzymes (XNAzymes) from diverse repertoires of synthetic genetic polymers. Nat. Protoc. 10, 1625-1642. doi: 10.1038/nprot.2015.104
117. Taylor, A. I., Pinheiro, V. B., Smola, M. J., Morgunov, A. S., Peak-Chew, S., Cozens, C., et al. (2015) Catalysts from synthetic genetic polymers. Nature 518, 427-430. doi: 10.1038/nature13982
118. Tei, S., Ishii, H. T., Mitsuhashi, H., and Ishiura, S. (2015). Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for congenital myasthenic syndromes. Biochem. Biophys. Res. Commun. 461, 481-486. doi: 10.1016/j.bbrc.2015.04.035
119. Toole, F., Brändle, G. M., Matzner, D., and Mayer, G. A. (2015). Versatile approach towards nucleobase-modified aptamers. Angew. Chem. Int. Ed Engl. 54, 10971-10974. doi: 10.1002/anie.201503652
120. Tuerk, C., and Gold, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510. doi: 10.1126/science.2200121
121. Vaish, N. K., Larralde, R., Fraley, A. W., Szostack, J. W., and McLaughlin, L. W. (2003). A novel, modification-dependent ATP binding aptamer selected from an RNA library incorporating a cationic functionality. Biochemistry 42, 8842-8851. doi: 10.1021/bi027354i
122. Vaught, J. D., Bock, C. H., Carter, J., Fitzwater, T., Otis, M., Schneider, D., et al. (2010). Expanding the Chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132, 4141-4151. doi: 10.1021/ja908035g
123. Veedu, R. N., Vester, B., and Wengel, J. (2007). Enzymatic incorporation of LNA nucleotides into DNA strands. Chembiochem 8, 490-492. doi: 10.1002/cbic.200600501
124. Veedu, R. N., Vester, B., and Wengel, J. (2008). Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates. J. Am. Chem. Soc. 130, 8124-8125. doi: 10.1021/ja801389n
125. Walsh, J. M., and Beuning, P. J. (2012). Synthetic Nucleotides as Probes of DNA Polymerase Specificity. J. Nucl. Acids 2012:530963. doi: 10.1155/2012/530963
126. Wandtke, T., Wozniak, J., and Kopinski, P. (2015). Aptamers in diagnostics and treatments of viral infections. Viruses 7, 751-780. doi: 10.3390/v7020751
127. Wiegand, T. W., Janssen, R. C., and Eaton, B. (1997). Selection of RNA amide synthases. Chem. Biol. 4, 675-683. doi: 10.1016/S1074-5521(97)90223-4
128. Wyss, L. A., Nilforoushan, A., Eichenseher, F., Suter, U., Blatter, N., Marx, A., et al. (2015). Specific incorporation of an artificial nucleotide opposite a mutagenic DNA Adduct by a DNA Polymerase. J. Am. Chem. Soc. 137, 30-33. doi: 10.1021/ja5100542
129. Xia, G., Chen, L., Sera, T., Fa, M., Schultz, P. G., and Romesberg, F. E. (2002). Directed evolution of novel polymerase activities: mutation of a DNA polymerase into an efficient RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 99, 6597-6602. doi: 10.1073/pnas.102577799
130. Yatime, L., Maasch, C., Hoehling, K., Anderson, G. R., and Vater, A. (2015). Structural basis for the targeting of complement anaphylatoxin C5a using a mix L-RNA/L-DNA aptamer. Nat. Commun. 6:6481. doi: 10.1038/ncomms7481
131. Yoshikawa, M., Kato, T., and Takenishi, T. (1967). A Novel method for phosphorylation of nucleosides to 5'-nucleotides. Tet. Lett. 50, 5065-5068. doi: 10.1016/S0040-4039(01)89915-9
132. Yüce, M., Ullah, N., and Budak, H. (2015). Trends in aptamer selection methods and applications. Analyst 140, 5379-5399. doi: 10.1039/C5AN00954E
133. Yu, H., Zhang, S., and Chaput, J. (2012). Darwinian evolution of an alternative genetic system provides support for TNA as an RNA progenitor. Nat. Chem. 4, 183-187. doi: 10.1038/nchem.1241
134. Zhou, C., Avins, J. L., Klauser, P. C., Brandsen, B. M., Lee, Y., and Silverman, S. C. (2016). DNA-Catalyzed Amide Hydrolysis. J. Am. Chem. Soc. 136, 2106-2109. doi: 10.1021/jacs.5b12647